MALDI Mass Spectrometry Imaging-Prognostic Pathways and Metabolites for Renal Cell Carcinomas.
Erlmeier F, Sun N, Shen J, Feuchtinger A, Buck A, Prade VM, Kunzke T, Schraml P, Moch H, Autenrieth M, Weichert W, Hartmann A, Walch A.
Erlmeier F, et al. Among authors: schraml p.
Cancers (Basel). 2022 Mar 30;14(7):1763. doi: 10.3390/cancers14071763.
Cancers (Basel). 2022.
PMID: 35406537
Free PMC article.